Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 4 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
CNO Financial's General Counsel sold $1.06M of CNO Financial shares. The filing does not indicate a pre-arranged trading plan.
Lately at CNO Financial Group: it signed an important agreement on Nov 13.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −17.0% · S&P 500 −5.8% · to Nov 20
Arm's Chief Architect sold $1.04M of Arm shares. The filing does not indicate a pre-arranged trading plan.
Lately at Arm Holdings: the stock is down 33% in 30 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −13.7% · S&P 500 −6.8% · to Nov 20
Gmr Solutions's President & COO sold $1.04M of Gmr Solutions shares. The filing does not indicate a pre-arranged trading plan.
Lately at Gmr Solutions: it reported its results on Nov 9; the stock is 36% below its 12-month high.
Insider selling
Traded Nov 18 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −14.1% · S&P 500 −5.5% · to Nov 20
A Flotek Industries director sold $753K of Flotek Industries shares. The filing does not indicate a pre-arranged trading plan.
Lately at Flotek Industries Inc: it reported its results on Nov 3; the stock is down 14% in 30 days; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +0.1% · S&P 500 −6.8% · to Nov 20
A Roivant Sciences director sold $738K of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +0.1% · S&P 500 −6.8% · to Nov 20
A Roivant Sciences director sold $738K of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −1.5% · S&P 500 −5.8% · to Nov 20
Church & Dwight's of Strategy, M&A, and BP sold $982K of Church & Dwight shares. The filing does not indicate a pre-arranged trading plan.
Lately at Church & Dwight: it reported its results on Oct 30; the stock is up 6% in 30 days; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −5.3% · S&P 500 −6.8% · to Nov 20
The CFO of EPAM Systems sold $298K of EPAM Systems shares. The filing does not indicate a pre-arranged trading plan.
Lately at EPAM Systems: the stock rose 21% in one session on Nov 5 around a company release; it signed an important agreement on Nov 10; the stock is up 14% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −6.4% · S&P 500 −5.8% · to Nov 20
A Universal Electronics director sold $704K of Universal Electronics shares. The filing does not indicate a pre-arranged trading plan.
Lately at Universal Electronics: the stock rose 14% in one session on Nov 11 with press coverage; it reported its results on Nov 5; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −8.3% · S&P 500 −6.8% · to Nov 20
An Advanced Drainage Systems director sold $695K of Advanced Drainage Systems shares. The filing does not indicate a pre-arranged trading plan.
Lately at Advanced Drainage Systems: the stock fell 15% in one session on Nov 5 around a company release; it signed an important agreement on Nov 10; the stock is down 15% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −4.3% · S&P 500 −5.8% · to Nov 20
Nexstar Media's President, Networks sold $830K of Nexstar Media shares. The filing does not indicate a pre-arranged trading plan.
Lately at Nexstar Media Group: it reported its results on Nov 5; the stock is up 19% in 30 days; insiders made no purchase ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −3.7% · S&P 500 −6.8% · to Nov 20
A Spectrum Brands director sold $533K of Spectrum Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Spectrum Brands Holdings: it reported its results on Nov 12; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 13 · filed 5 days laterNot reported under a pre-arranged trading plan
Since the trade −15.0% · S&P 500 −8.6% · to Nov 20
An Arista Networks director sold $492K of Arista Networks shares. The filing does not indicate a pre-arranged trading plan.
Lately at Arista Networks: the stock fell 12% in one session on Nov 20 with press coverage; it reported its results on Nov 3; the stock is down 9% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −5.1% · S&P 500 −5.8% · to Nov 20
GE Aerospace's Senior Vice President sold $657K of GE Aerospace shares. The filing does not indicate a pre-arranged trading plan.
Lately at GE Aerospace: it reported its results on Oct 20; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −2.4% · S&P 500 −5.8% · to Nov 20
A Riskified director sold $485K of Riskified shares. The filing does not indicate a pre-arranged trading plan.
Lately at Riskified: the stock rose 22% in one session on Nov 11 with press coverage; the stock is up 6% in 30 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −1.4% · S&P 500 −6.8% · to Nov 20
An Expeditors International director sold $480K of Expeditors International shares. The filing does not indicate a pre-arranged trading plan.
Lately at Expeditors International: it reported its results on Nov 18.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −3.6% · S&P 500 −5.8% · to Nov 20
A Pcb Bancorp director sold $452K of Pcb Bancorp shares. The filing does not indicate a pre-arranged trading plan.
Lately at Pcb Bancorp: it reported its results on Oct 29.
Insider selling
Traded Nov 18 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade +0.3% · S&P 500 −5.5% · to Nov 20
Bancfirst's Senior Vice President sold $594K of Bancfirst shares. The filing does not indicate a pre-arranged trading plan.
Lately at Bancfirst Corp: it reported its results on Oct 22; the stock is up 8% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −3.9% · S&P 500 −5.8% · to Nov 20
A Regeneron Pharmaceuticals director sold $446K of Regeneron Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Lately at Regeneron Pharmaceuticals: the stock rose 13% in one session on Oct 30 around a company release; it reported its results on Oct 30; the stock is up 14% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +4.9% · S&P 500 −5.8% · to Nov 20
A Rapid7 director sold $416K of Rapid7 shares. The filing does not indicate a pre-arranged trading plan.
Lately at Rapid7: the stock rose 20% in one session on Oct 26 with press coverage; it reported its results on Nov 4; the stock is up 6% in 30 days.